Statistics

Total Visits

Views
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial69

Select a period of time:

Number of views in the range

Views
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial9

Views

Views
December 20251
January 20260
February 20261
March 20261
April 20261
May 20265
June 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Canada2
Brazil1
Spain1
Finland1
United Kingdom1
 

Top cities views

Views
Callosa d'En Sarrià1
Charlton1
Draper1
Fort McMurray1
Helsinki1
Jacksonville1
Jaguariaíva1